Programme  Titles  Presenters  Topics 
Sunday, 18 September 2016
11:00-12:50  Registration
Hall Tramuntana -1 Floor
12:50-13:00  Opening Remarks - Mike Bray
Tramuntana II/III, Floor-1
13:00-13:50  Keynote lecture: Marie-Paule Kieny, Assistant Director General, World Health Organization, Switzerland - “Lessons learned from conducting R & D in the middle of the Ebola epidemic”
Tramuntana II/III, Floor-1
13:50-15:00  Refreshment break
Tramuntana I and Foyer
15:00-17:00  Plenary Session 1
Tramuntana II/III, Floor-1
15:00-16:00  Ralf Bartenschlager - New insights into the flavivirus replication cycle: Implications for antiviral therapy
Tramuntana II/III, Floor-1
16:00-17:00  Christian Drosten - MERS-coronavirus emergence and functional variability
Tramuntana II/III, Floor-1
17:00-18:00  Welcome Reception
Tramuntana I and Foyer
 
Monday, 19 September 2016
08:30-10:30  Plenary Session 2
Tramuntana II/III, Floor-1
08:30-09:00  David Durantel - Novel therapeutic insights for hepatitis B virus infections: what's coming next?
Tramuntana II/III, Floor-1
09:00-09:30  Mark Prichard - New therapies for DNA viral infections
Tramuntana II/III, Floor-1
09:30-10:00  Katherine Seley-Radtke - Rational strategies in nucleoside drug design
Tramuntana II/III, Floor-1
10:00-10:30  Andrew Mesecar - Proteases as antiviral drug targets: successes and challenges
Tramuntana II/III, Floor-1
10:30-11:00  Refreshment break
Tramuntana I and Foyer
11:00-13:00  Current Research 1
Tramuntana II/III, Floor-1
13:00-15:00  Lunch
Restaurant Marquee , Floor 0
13:30-14:30  Author Workshop: How to Get Published
Tramuntana II/III, Floor-1
15:00-17:00  Plenary Session 3
Tramuntana II/III, Floor-1
15:00-15:40  Stephan Günther - Research on Ebola and Lassa fever: From Hamburg to West Africa
Tramuntana II/III, Floor-1
15:40-16:20  Jens Bukh - Challenges and opportunities in hepatitis C research
Tramuntana II/III, Floor-1
16:20-17:00  Louise Taylor - Rabies: A global perspective
Tramuntana II/III, Floor-1
17:00-18:30  Poster Session
Tramuntana I, Floor-1
19:00-22:00  Networking Evening [ticketed event]
 
Tuesday, 20 September 2016
08:30-10:30  Plenary Session 4
Tramuntana II/III, Floor-1
08:30-09:00  José Esté - Deciphering innate immunity against HIV-1
Tramuntana II/III, Floor-1
09:00-09:30  Luis Menéndez Arias - HIV drug resistance: Questions and new challenges
Tramuntana II/III, Floor-1
09:30-10:00  Jennifer McKimm-Breschkin - Targeting the ins and outs of influenza
Tramuntana II/III, Floor-1
10:00-10:30  Lieve Naesens - Update on influenza inhibitors acting on viral RNA synthesis
Tramuntana II/III, Floor-1
10:30-11:00  Refreshment break
Tramuntana I and Foyer
11:00-13:00   Current Research 2
Tramuntana II/III, Floor-1
13:00-14:00  Lunch, free afternoon
Restaurant Marquee , Floor 0
 
Wednesday, 21 September 2016
08:30-10:30  Plenary Session 5
Tramuntana II/III, Floor-1
08:30-09:00  Subhash Vasudevan - The many faces of the flavivirus NS5 protein: vulnerability vs. druggability
Tramuntana II/III, Floor-1
09:00-09:30  Sina Bavari - Emerging antivirals for highly pathogenic viruses
Tramuntana II/III, Floor-1
09:30-10:00  Colleen Jonsson - Hantaviruses: Global overview of reservoirs, cross-species transmission and disease
Tramuntana II/III, Floor-1
10:00-10:30  Rolf Hilgenfeld - Zika virus NS2B-NS3 protease: Crystal structure and inhibitors
Tramuntana II/III, Floor-1
10:30-11:00  Refreshment break
Tramuntana I and Foyer
11:00-13:00   Current Research 3
Tramuntana II/III, Floor-1
13:00-14:00  Lunch
Restaurant Marquee , Floor 0
14:00-16:00  Plenary Session 6
Tramuntana II/III, Floor-1
14:00-14:40  Sheemei Lok - Structural studies of dengue and Zika virus
Tramuntana II/III, Floor-1
14:40-15:20  Thijn Brummelkamp - Viral entry mechanisms unravelled using haploid genetics
Tramuntana II/III, Floor-1
15:20-16:00  Johan Neyts - Antiviral research: Much accomplished, far to go
Tramuntana II/III, Floor-1
16:00-16:30  Closing Address
Tramuntana II/III, Floor-1
 
  Copyright © 2016 Elsevier Limited. Privacy | Terms | Cookies
Powered by Oxford Abstracts. Cookies are set by this site. To decline them or learn more, visit our Cookies page.